TUM – Technical University of Munich Menu
Am 23. September unterzeichneten Vertreter der TUM und der  Klaus Tschira Stiftung den Vertrag über die Förderung für das neue Forschungszentrum: v.l.n.r.: Harald Tschira, Geschäftsführender Gesellschafter der Klaus Tschira Stiftung; Beate Spiegel, Geschäftsführerin der Klaus Tschira Stiftung, Prof. Wolfgang A. Herrmann, Präsident der TUM. (Foto: A. Eckert / TUM)
Am 23. September unterzeichneten Vertreter der TUM und der Klaus Tschira Stiftung den Vertrag über die Förderung für das neue Forschungszentrum: v.l.n.r.: Harald Tschira, Geschäftsführender Gesellschafter der Klaus Tschira Stiftung; Beate Spiegel, Geschäftsführerin der Klaus Tschira Stiftung, Prof. Wolfgang A. Herrmann, Präsident der TUM. (Foto: A. Eckert / TUM)
  • Research news

The Klaus Tschira Foundation funds new TUM research center

25 million euros for multiple sclerosis research

As one of the central fields of medical research at the Technical University of Munich (TUM), neuroscience is to gain a new research center for multiple sclerosis (MS). In Germany alone, some 200,000 people are affected by this as yet incurable disease, the cause of which remains unknown. Researchers at the TUM Klinikum rechts der Isar will now focus on MS and link clinical aspects of the disease with basic research. This major project has been enabled thanks to a 25 million euro donation by the Klaus Tschira Foundation, established by physicist Klaus Tschira. The associated contract was signed today by the President of TUM, Prof. Wolfgang A. Herrmann, and Directors of the Klaus Tschira Foundation, Beate Spiegel and Harald Tschira.

In multiple sclerosis, the most common inflammatory disease of the central nervous system, the protective outer coating of the nerves is attacked and destroyed by the body's own immune system, for reasons that are as yet unknown. The loss of this protective coating results in damage to the nerve fibers of the brain and spinal cord. Symptoms range from sensations of numbness to visual disorders, loss of coordination, problems with concentration and even paralysis.

Each year, 1000 MS patients receive treatment at TUM Klinikum rechts der Isar, and numerous research groups there study the disease. The Klaus Tschira Foundation’s comprehensive financial support will now be used to establish a new MS treatment and research center within the grounds of the university hospital.

"We are convinced that bringing outstanding scientists together in this new center will make a vital contribution to advancing research into the causes and treatment of MS", say Harald Tschira and Beate Spiegel in relation to the Klaus Tschira Foundation's involvement. "Of the 25 million euros, 20 million are for construction and 5 million for research."

TUM President Herrmann is very pleased: "The new research center will be a great success, and we thank the Klaus Tschira Foundation for it. The new build will give the excellent scientists already working at the Technical University of Munich a shared address right in the middle of the medical campus of TUM Klinikum rechts der Isar. This generous donation substantiates our reputation in neuroscience, recently boosted once more by the appointment of top researcher Prof. Mikael Simons from Göttingen."

Building on existing: MS research at TUM

The main effect of the new build will be to bring the existing MS-related research groups at TUM together under a single roof. Scientists working on basic research and clinical research will work closely together to ensure that new discoveries are quickly translated into practical applications. As well as studying the immune system, scientists in the new research center will investigate the mechanisms that trigger damage to the nerve coatings and to the nerve fibers themselves. Their findings will feed into new therapeutic approaches, targeting especially the progressive stage of the disease.

"This research center will be unique in Germany, with doctors and scientists in areas ranging from clinical practice to basic research working together under a single roof", says Prof. Bernhard Hemmer, Director of the Department of Neurology, TUM Klinikum rechts der Isar. "MS patients will be the main beneficiaries of this new structure, since the systematic utilization of research results extends the range of treatment options and will one day enable individualized treatment of the disease."

More information

•    Klaus Tschira Foundation
•    Department of Neurology, TUM Klinikum rechts der Isar

Corporate Communications Center

Technical University of Munich Dr. Vera Siegler
vera.siegler(at)tum.de

Article at tum.de

PD Dr. Alexander Hapfelmeier (left) and Prof. Bernhard Hemmer discuss the results of the MS-study.

Vaccinations not a risk factor for multiple sclerosis

Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population’s vaccination behavior in relation to MS. It showed that five...

Prof. Thomas Korn untersucht die Rolle der B-Zellen bei der Multiplen Sklerose. (Bild: M. Jooss / TUM)

Damage in MS from B cells in meninges

B cells are important in helping the immune system fight pathogens. However, in the case of the neurological autoimmune disease Multiple Sclerosis (MS) they can damage nerve tissue. When particular control cells are...

Explaining mathematics metaphorically

As clear as mathematics may be, for many it remains incomprehensible. That is why Katharina Schaar, a mathematician with a doctorate from the Technical University of Munich (TUM), uses analogies when talking about her work....

Der Thiersch-Turm, ein markanter Punkt in der Münchner Silhouette. (Bild: A. Heddergott / TUM)

Tschira Forum opens

Since its completion in 1916, the “Thiersch Tower” is the landmark of the Technical University of Munich (TUM). To TUM president Wolfgang A. Herrmann it represents the “Soul of the university”. On the occasion of the 150th...

Das neue OP-Zentrum Nord des Klinikums rechts der Isar. (Bild: Stobrawe / MRI)

State of the art surgery

The Surgery Center North ("OP-Zentrum Nord") was inaugurated yesterday at the Technical University of Munich's TUM Klinikum rechts der Isar hospital. The facility, featuring approximately 4,150 square meters of utilizable...

Bei der Schlüsselübergabe für das Klinikum im Jahr 1967 (v.l.): Dr. Ludwig Huber, Staatsminister für Unterricht und Kultus, Dr. Hans-Jochen Vogel, Oberbürgermeister der Stadt München, und Prof. Gerd Albers, Rektor der TH München.

Celebration for cutting-edge medicine

The establishment of the school of medicine at the Technical University of Munich (TUM) in 1967 was something of a political bombshell. The city already had a faculty of medicine, and even today technical universities with...

Zwei Ärtze betrachten Gehirnscans.

Tailoring individual therapies for Multiple Sclerosis

A large global new partnership called 'MultipleMS', coordinated by Karolinska Institute in Sweden, has been awarded 15 million euro from the European Commission in the Horizon2020 program to find novel and better treatments...

Am TranslaTUM werden interdisziplinäre Teams aus Ingenieuren, Naturwissenschaftlern und Medizinern gemeinsam daran arbeiten, um wissenschaftliche Erkenntnisse rasch in praktische Anwendungen zu „übersetzen“. Diese Translation war namensgebend für das Zentrum. (Bild: doranth post architekten GmbH)

TUM sets the next milestone in biomedicine

Translational cancer research will be the focus of the new TranslaTUM central institute at the Technical University of Munich (TUM). The topping-out ceremony for the new research building (investment volume of approx. EUR...

Autoantikörper binden an  Gliazellen

Multiple sclerosis: New marker could improve diagnosis

Diagnosing multiple sclerosis (MS) is a challenge even for experienced neurologists. This autoimmune disease has many symptoms and rarely presents a uniform clinical picture. New scientific findings on the immune response...